C6X-28614-10308
2 vaccinations
6 coded responses
24 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 722 / AR
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Dose 1 — Pfizer-BioNTech
-
2021-03-20
Registered in v-safe
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Rash, Rash pruritic — Feeling: Good · Site: PainFree text: very small itching rash behind left kneeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-21
-
2021-03-22
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Dyspnoea, Rash, Sinus congestion, Sneezing — Feeling: GoodFree text: coughing, sneezing, shortness of breath, sinus congestion, light rash on various limbsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Survey response — days 1–6 daily, dose 1MedDRA: Sinus congestion — Feeling: GoodFree text: mild sinus congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: GoodFree text: some weakness in chest and abdominal area, but may be more related to rituxan infusion than vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
- 2021-03-26
- 2021-04-02
-
2021-04-09
Dose 2 — Pfizer-BioNTech
- 2021-04-09
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia — Feeling: Good · Site: PainFree text: a single pearcing pain in the vicinity of my right kidneyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches · Be unable to workAdult check-in
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-07-09
- 2021-10-11
- 2022-04-01
-
2022-04-09
Survey response — 12 months, dose 2MedDRA: Chills, Cold sweat, Constipation, Cough, Diarrhoea, Dyspnoea, Myalgia, Pyrexia, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Tested positive for COVID. Had moderately severe symptoms for about a month including: fever, cold-sweats, chills, muscle aches, diarrhea, constipation, shortness of breath, uncontrollable coughing, etc. Blood O2 levels remained between 93%-98%.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-09
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2022-04-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-09 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): very small itching rash behind left knee
Systemic reaction (other): coughing, sneezing, shortness of breath, sinus congestion, light rash on various limbs
Systemic reaction (other): mild sinus congestion
Systemic reaction (other): some weakness in chest and abdominal area, but may be more related to rituxan infusion than vaccine
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): a single pearcing pain in the vicinity of my right kidney
Release 11 — 12 months, dose 2
Symptoms: Tested positive for COVID. Had moderately severe symptoms for about a month including: fever, cold-sweats, chills, muscle aches, diarrhea, constipation, shortness of breath, uncontrollable coughing, etc. Blood O2 levels remained between 93%-98%.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cold sweat | · | · | ✓ |
| SD | Constipation | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rash pruritic | ✓ | ✓ | ✓ |
| SRO | Sinus congestion | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release